Jonathan Webster
-
- Pituitary Gland Disorders and Treatments 17
- Growth Hormone and Insulin-like Growth Factors 16
- Research and Theory top 5%
- Hematology top 5%
- Acute Myeloid Leukemia Research 17
- Chronic Myeloid Leukemia Treatments 11
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
-
- Acute Lymphoblastic Leukemia research 18
-
- CAR-T cell therapy research 8
-
- Adrenal and Paraganglionic Tumors 7
- Co-authors
- M. F. ScanlonJohn S. BevanCarlo FerrariG. PiscitelliC. W. BURKEIkram Shah IsmailAnna PolliPeak Mann Mah
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Jonathan Webster
93 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Endocrinology, Diabetes and Metabolism 1.4k
- Research and Theory 45
- Hematology 199
- Issues, ethics and legal aspects 22
- Genetics 185
Countries citing papers authored by Jonathan Webster
This map shows the geographic impact of Jonathan Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Webster more than expected).
Fields of papers citing papers by Jonathan Webster
This network shows the impact of papers produced by Jonathan Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Webster. The network helps show where Jonathan Webster may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan Webster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 19 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 2 | |
| 11 | 2017 | 44 | |
| 12 | 2015 | 77 | |
| 13 | 2010 | 30 | |
| 14 | Improving nutrition for older people in hospital by assessing current practice. | 2009 | 1 |
| 15 | 2009 | 4 | |
| 16 | 'We all need to challenge practices that do not value a person's right to dignity'. | 2007 | 3 |
| 17 | The abuse of older people. | 2005 | 2 |
| 18 | Leading the switch to patient-centred care. | 2004 | 2 |
| 19 | 2003 | 2 | |
| 20 | 1993 | 50 |
About Jonathan Webster
Jonathan Webster is a scholar working on Hematology, Issues, ethics and legal aspects, Endocrinology, Diabetes and Metabolism, Research and Theory and Genetics, having authored 102 papers that have together received 3.0k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (18 papers), Pituitary Gland Disorders and Treatments (17 papers), Acute Myeloid Leukemia Research (17 papers), Growth Hormone and Insulin-like Growth Factors (16 papers), Chronic Myeloid Leukemia Treatments (11 papers), CAR-T cell therapy research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Adrenal and Paraganglionic Tumors (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Research and Theory (45 citations), Hematology (199 citations), Issues, ethics and legal aspects (22 citations) and Genetics (185 citations). Jonathan Webster has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include M. F. Scanlon, John S. Bevan, Carlo Ferrari, G. Piscitelli, C. W. BURKE, Ikram Shah Ismail, Anna Polli, Peak Mann Mah, Kim Manley and Keith W. Pratz. Their work appears in journals such as Blood, Haematologica, Clinical Endocrinology, The Journal of Clinical Endocrinology & Metabolism and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.